Proper Name: Ebola Zaire Vaccine, Live
Manufacturer: Merck Sharp & Dohme Corp.
- ERVEBO is a vaccine indicated for the prevention of disease caused by Zaire ebolavirus in individuals 18 years of age and older.
- Package Insert - ERVEBO
- Patient Information - ERVEBO
- Demographic Subgroup Information – ERVEBO (Ebola Zaire Vaccine, Live)
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.
- September 16, 2022 Approval Letter - ERVEBO
- December 19, 2019 Approval Letter - ERVEBO
- December 19, 2019 Summary Basis for Regulatory Action - ERVEBO
- Statistical Review - ERVEBO
- Approval History, Letters, Reviews, and Related Documents - ERVEBO